ain
Half of brain tumor patients report pain, including chronic headaches from craniotomy (responding to anal- gesics), acute headaches from edematous reaction to ra- diotherapy or increased intracranial pressure secondary to the tumor itself (both responding to steroids), neuro- pathic pain secondary to meningeal involvement, zona, or complications of chemotherapy (responding to AEDs and a topical lidocaine patch for allodynia) [1••]. Gaba- pentin is currently under assessment for primary preven- tion of chemotherapy-induced neuropathy [9]. Vincris- tine may induce diffuse myalgias/arthralgias that respond to analgesics and nonsteroidal-antiinflammatories.